← Back to Search

Ancillary-correlative (biospecimen collection) for Cancer

N/A
Recruiting
Led By Jeffrey N Weitzel
Research Sponsored by City of Hope Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

This trial is looking at the role of genes and behavior in cancer development, and how these factors can affect cancer outcomes in patients with a history of cancer and their relatives.

Eligible Conditions
  • Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

1Treatment groups
Experimental Treatment
Group I: Ancillary-correlative (biospecimen collection)Experimental Treatment2 Interventions
Participants may provide a sample of blood, a saliva sample, a sample of eyebrow plucks, a sample of urine, and/or stored tumor or healthy tissue.

Find a Location

Who is running the clinical trial?

City of Hope Medical CenterLead Sponsor
596 Previous Clinical Trials
923,538 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,842 Previous Clinical Trials
40,003,001 Total Patients Enrolled
Jeffrey N WeitzelPrincipal InvestigatorCity of Hope Medical Center
~169192 spots leftby May 2030
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top